Nabanir Hospital & Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.49%
- Profit Growth -14.42%
- Ebitda -15.35%
- Net Worth 29.65%
- Total Assets 20.82%
About Nabanir Hospital & Diagnostics
Nabanir Hospital & Diagnostics Private Limited (NHDPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 2016 (Nine years and one month 9 days old ). Its registered office is in Howrah, West Bengal, India.
The Corporate was formerly known as Nabanna Hospital & Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Milan Chakrabarti and Sabyasachi Chakraborti serve as directors at the Company.
Company Details
- Location
Howrah, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900WB2016PTC209210
- Company No.
209210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Nabanir Hospital & Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Chakrabarti  | Director | 11-Jan-2016 | Current |
| Sabyasachi Chakraborti | Director | 11-Jan-2016 | Current |
Financial Performance of Nabanir Hospital & Diagnostics.
Nabanir Hospital & Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.49% decrease. The company also saw a substantial fall in profitability, with a 14.42% decrease in profit. The company's net worth Soared by an impressive increase of 29.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nabanir Hospital & Diagnostics?
Unlock access to Nabanir Hospital & Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nabanir Hospital & Diagnostics?
Nabanir Hospital & Diagnostics has a workforce of 44 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nabanir Hospital & Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nabanir Hospital & Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
